Cholangiopancreatography, Endoscopic Retrograde Clinical Trial
Official title:
A Randomized Controlled Trial of the Double Wire Technique With or Without Transpancreatic Sphincterotomy for Difficult Common Bile Duct Cannulation
Endoscopic cholangiography is a procedure which is performed to image the bile duct and
perform therapy like removal of bile duct stones. It is currently standard of care to remove
stones from the bile duct when found as they frequently cause complications like infections
which can sometime be life threatening.
Therapy on the biliary tree, like for example stone removal, frequently requires inserting
tools through the opening of the duct and cutting of the muscle which control the secretion
of juices from the liver. Cutting the muscle helps with securing an easy access to the bile
duct. It also helps facilitating dragging the stones out. On certain occasions placing a wire
in the bile duct fails and instead the wire keeps entering the pancreatic duct whose opening
is adjacent to the bile duct opening. There is evidence to suggest that keeping a wire in the
pancreatic duct facilitates placing a second wire in the bile duct possibly because it
straightens the duct. On certain occasions this also fails and we resort to cutting the
muscle of the pancreas and the bile duct simultaneously to facilitate the access to the bile
duct. The more attempt to enter the bile duct the higher the risk of inflammation in the
pancreas known as pancreatitis. This makes decreasing the number of attempts at placing the
wire in the duct desirable. One way to facilitate placement of the wire in the bile duct is
to cut starting from the opening of the pancreas duct aiming toward the bile duct muscle.
This often cuts the bile duct sphincter and exposes the bile duct opening. The study is
trying to answer if cutting the bile duct sphincter muscle in the direction of the bile duct
immediately after a wire has entered the pancreatic duct will make it easier to place the
wire in the bile duct as compared to trying to place the wire in the bile duct without
cutting the opening. While cutting the muscle canincrease the risk of pancreatitis, repeated
attempts at accessing the bile duct can also increase the risk of pancreatitis. So if cutting
the pancreatic muscle will facilitate entry to the bile duct and decrease the number of
attempts at entering the bile duct then it might be a better way to approach the patient whom
we had difficulty in entering the bile duct.
This will be a prospective, non blinded randomized controlled trial. We will screen and offer
enrollment to all patients presenting to Mayo Clinic Arizona for an ERCP who have a native
papilla and an indication for cholangiography and sphincterotomy. Informed consent will be
obtained in the preoperative area after obtaining consent for the ERCP. We will randomize all
patients in whom we fail to deeply cannulate the CBD using a sphincterotome (Autotome, Boston
Scientific) and 0.035" guidewire (0.035" Jagwire or Dreamwire, Boston Scientific) in over 5
minutes or with more than 5 attempts and in whom the wire can be passed in a stable
configuration in the Pancreatic duct (PD). We will exclude patients who have any
contraindication to undergoing an ERCP, contraindications to sphincterotomy (e,g,, abnormal
anatomy, uncorrectable coagulopathy) and those who have pancreas divisum. Patients will be
randomized 1:1 using opaque envelopes in blocks of 4 stratified for gender. (Gender
stratification is necessary as the risks of ERCP vis pancreatitis are different for males and
females). In those randomized to the DWT group, the PD wire will be left in place, the
catheter removed and then reinserted next to the PD wire with a second wire to attempt CBD
cannluation as previously described (1). In those randomized to TPS, a pancreatic
sphincterotomy will be performed with the sphincterotome. The catheter will be removed with
the PD wire left in place. The catheter and a second wire will be inserted and CBD
cannluation attempted as for the DWT group. All patients will receive a 5Fr pancreatic stent
and indomethacin 100 mg rectally to reduce the risk of pancreatitis as per our standard of
care (patients with contraindications to NSAIDs (e.g., sensitivity to Indomethacin, aspirin
or class, active peptic ulcer disease) will not receive Indomethacin. Patients who fail DWT
(at least 10 minutes or 10 further attempts) may be crossed over to TPS at the endoscopist's
discretion. Further care the patients receive will be standard of care. We will contact the
patients around a months later by telephone to ask about any procedure related complications
that were not reported to us.
outcome measures will be assessed on day 1 at the end of the procedure and on day 30.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05035433 -
Effect of the Sequence of Dilatation and Lithotripsy on the Treatment of Choledocholithiasis With ERCP
|
N/A | |
Completed |
NCT02985164 -
Radiation Exposure During Endoscopic Retrograde Cholangiopancreatography
|
Phase 3 | |
Completed |
NCT05533944 -
Fast-tracking ERCP Learning: Does Training on a Mechanical Simulator Improve Trainee's Clinical Performance?
|
N/A | |
Suspended |
NCT04559867 -
Fistulotomy as the Primary Cannulation Technique for All Patients Undergoing ERCP: A Randomized, Controlled Trial
|
N/A | |
Active, not recruiting |
NCT05592795 -
Explore the Effects and Mechanisms of ERCP and EST on Biliary Microecology
|
||
Enrolling by invitation |
NCT04719117 -
Retrograde Cholangiopancreatography AI Assisted System Validation on Effectiveness and Safety
|
||
Enrolling by invitation |
NCT04572711 -
Prospective Evaluation of Biliary Tissue Sampling With ERCP
|
||
Completed |
NCT03263481 -
Intraductal Secretin Stimulation Test: What Is the Proper Collection Time?
|
N/A | |
Completed |
NCT03292627 -
Non-invasive Monitor in Endoscopic Invasive Procedure
|
||
Recruiting |
NCT06265311 -
IDUS in CBD Stone Recurrence High Risk Patients
|
N/A | |
Completed |
NCT06031363 -
The Optimal Dose of Indomethacin Suppository for Preventing Post-ERCP Pancreatitis
|
N/A | |
Recruiting |
NCT05261997 -
Endotherapy for Painless Chronic Pancreatitis
|
N/A | |
Completed |
NCT02698137 -
Quality Assessment in Endoscopic Retrograde Cholangiopancreatography(ERCP)
|
||
Recruiting |
NCT05246657 -
EUS-guided Entero-biliary Anastomosis for Therapeutic Access in Benign Biliary Obstructions
|
||
Recruiting |
NCT04910087 -
The Effect of Anesthesia Management on Optic Nerve Sheath Diameter in the Ercp Procedures
|
N/A | |
Recruiting |
NCT05303662 -
Prevalence of Multidrug Resistant Micro-organism Carriage in Patients Undergoing an ERCP in Four Different Countries
|
||
Terminated |
NCT05129449 -
A Clinical Study With the Medical Device PowerSpiral for Endoscopic Retrograde Cholangio-Pancreatography (ERCP)
|
||
Completed |
NCT03561441 -
Tailored Hydration for the Prevention of Post-ERCP Pancreatitis
|
N/A | |
Not yet recruiting |
NCT06196164 -
A RCT of Low MBO Drainage Strategies
|
N/A | |
Completed |
NCT03490383 -
Study of Microbiota in Bile From Patients With Common Bile Duct Stone During ERCP
|